An intense five-month competition came to an end Tuesday evening as Innovacorp announced the provincial winner of the I-3 Technology Start-Up Competition. MorSwift Machines Inc. from Digby NS, was awarded a $100,000 seed equity investment from Innovacorp.
Check out some images from Innovacorp's I-3 Technology Start-Up Competition awards event - February 12, 2008.
See below for images from the awards event for Innovacorp's I-3 Technology Start-Up Competition - February 12, 2008.
All photos: (c) 2008 STEVEKAISERPHOTOGRAPHY.CA
EastMed Inc., a medical manufacturing company that caters specifically to women's health and wellness, welcomes two new members to its team: James Lodigiani, CEO, and Jeff Smith, chairman of the board.
“We are delighted to enhance our team with this caliber of talent,” said Dr. Scott Farrell, EastMed president and head of the urogynaecology division at the IWK Health Centre.
“Both Jim and Jeff bring tremendous experience in the successful introduction of health and wellness products to the marketplace. And they have expertise in leading start-up organizations.”
ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada’s regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax® platform.
ImmunoVaccine Technologies Inc. (IVT), announced today that it had signed licensing agreements for Pfizer Animal Health to apply IVT's novel VacciMax® vaccine platform to the potential development of future, particular livestock vaccines.
Although terms of the agreements were not disclosed, IVT will receive upfront signing fees, milestone and royalty payments.
ImmunoVaccine Technologies Inc. (IVT), a Nova Scotia-based vaccine enhancement company, has signed a binding memorandum of understanding to acquire Immunotope Inc., a Pennsylvania-based biotechnology company developing immunotherapy products for the treatment and prevention of cancer and infectious diseases.
Innovacorp welcomes the Association of Internationally Educated and Trained Professionals of Nova Scotia (IETP - NS) to the Technology Innovation Centre.
The staff and clients of Innovacorp welcome our newest client, Connecting People for Health Co-operative Ltd. (CPHCi).
CPHCi is committed to connecting people to the health care system and to communities of support through the use of information technology. CPHCi believes that an empowered and supported patient improves individual, family, and community health and well-being, and can eventually transform the delivery of health care.
EastMed Inc., an Atlantic Canadian medical manufacturing company that caters specifically to women's health and wellness, officially launched its very first product in Halifax today.
The uresta™ Continence Care Kit, EastMed’s flagship product designed to stop bladder leakage, is expected to empower women to self-manage their stress urinary incontinence (SUI) with a breakthrough alternative to traditional products.
Innovacorp is a proud partner in BioPort Atlantic 2007, happening September 26-27, 2007, at the World Trade and Convention Centre.
BioPort Atlantic is the annual signature event for Atlantic Canada’s life sciences industry. Presented by BioNova – The Nova Scotia Biotechnology and Life Sciences Industry Association, this exciting conference draws members of the life sciences and business communities from across North America and abroad.
A line-up of top notch speakers and panel presentations has been announced for the Atlantic region’s annual life sciences conference.